Dr. S. Can Ozcan holds a D.V.M. degree from Uludag University. He completed his doctoral studies at Uludag University in the field of biochemistry and cancer cell metabolism. His doctoral studies were focused on the role of PFKFB enzymes on oncogenic transformation of panreatic ductal cells. He worked as a researcher in many projects funded by TUBITAK, EU Marie Curie, Kentucky Lung Cancer Research Program and NIH. He was the recipient of TUBITAK 2214 research scholarship and spent a year in Dr. Jason Chesney’s lab in Louisville, USA. Dr. Ozcan’s post-doctoral research aims involve to understand the role of Nek2A on centrosome biology and cellular division disorders, and to identify cell cycle specific interactome of Nek2A in cancers.
Ozcan, S. C., Sarioglu, A., Altunok, T. H., Akkoc, A., Guzel, S., Guler, S., … & Clem, A. L. (2020). PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells. Molecular and Cellular Biochemistry.
Yalcin, A., Solakoglu, T. H., Ozcan, S. C., Guzel, S., Peker, S., Celikler, S., … & Chesney, J. A. (2017). 6-phosphofructo-2-kinase/fructose 2, 6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro. Biochemical and Biophysical Research Communications, 484(3), 687-693.
Yalcin, A., Clem, B. F., Imbert-Fernandez, Y., Ozcan, S. C., Peker, S., O’neal, J., … & Chesney, J. (2014). 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27. Cell Death & Disease, 5(7), e1337-e1337.